Plus Therapeutics Inc (NASDAQ: PSTV) is -72.78% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.34 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.31, the stock is -45.49% and -58.98% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.01 million and changing -7.72% at the moment leaves the stock -72.99% off its SMA200. PSTV registered -85.64% loss for a year compared to 6-month loss of -73.70%. The firm has a 50-day simple moving average (SMA 50) of $0.7632 and a 200-day simple moving average (SMA200) of $1.15915.
The stock witnessed a -68.17% gain in the last 1 month and extending the period to 3 months gives it a -73.92%, and is -38.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.00% over the week and 11.36% over the month.
Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $5.32M and $5.82M in sales. Profit margin for the company is -222.84%. Distance from 52-week low is 30.42% and -88.28% from its 52-week high.
The EPS is expected to grow by 57.69% this year
17.0 institutions hold shares in Plus Therapeutics Inc (PSTV), with institutional investors hold 7.98% of the company’s shares. The shares outstanding are 17.00M, and float is at 16.57M with Short Float at 12.57%. Institutions hold 7.50% of the Float.
Plus Therapeutics Inc (PSTV) Insider Activity
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).
